|Manufacturer:||QOL Medical, LLC|
Each bottle of SUCRAID is supplied with a plastic screw cap which covers a dropper dispensing tip.
Remove the outer cap and measure out the required dose.
Reseal the bottle after each use by replacing and twisting the cap until tight.Write down the date the sealed bottle is first opened in the space provided on the bottle label.
Always throw away the bottle four weeks after first opening it because SUCRAID contains no preservatives.
For the same reason, you should rinse the measuring scoop with water after each time you finish using it.To get the full benefits of this medicine, it is very important to take SUCRAID as your doctor has prescribed.
The usual dosage is 1 to 2 milliliters (mL) with each meal or snack:1 mL = 1 full measuring scoop (28 drops from the bottle tip) and 2 mL = 2 full measuring scoops (56 drops from the bottle tip).Measure your dose with the measuring scoop provided (see Figure 1).
Do not use a kitchen teaspoon or other measuring device since it will not measure an accurate dose.Figure 1.
Measure dose with measuring scoop.Mix your dose in 2 to 4 ounces of water, milk, or infant formula (see Figure 2). SUCRAID should not be dissolved in or taken with fruit juice.NEVER HEAT SUCRAID OR PUT IT IN WARM OR HOT BEVERAGES OR INFANT FORMULA.
Heating SUCRAID causes it to lose its effectiveness. The beverage or infant formula should be taken cold or at room temperature.Figure 2.Mix dose in beverage or infant formula.It is recommended that approximately half of your dosage be taken at the beginning of each meal or snack and the remainder of your dosage be taken during the meal or snack.
SUCRAID (sacrosidase) oral solution is indicated as oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency.(CSID)
Severe wheezing, 90 minutes after a second dose of sacrosidase, necessitated admission into the ICU for a 4-year old boy.
The wheezing was probably caused by sacrosidase.
He had asthma and was being treated with steroids. A skin test for sacrosidase was positive.Other serious events have not been linked to SUCRAID.